Scarica l'app Stockscreener
9.8305
0.72%
0.0805
Precedente Chiudi:
$9.75
Aprire:
$9.89
Volume 24 ore:
50,637
Relative Volume:
0.08
Capitalizzazione di mercato:
$909.53M
Reddito:
$81.39M
Utile/perdita netta:
$-114.20M
Rapporto P/E:
-6.8971
EPS:
-1.4253
Flusso di cassa netto:
$-50.60M
1 W Prestazione:
+9.72%
1M Prestazione:
+3.15%
6M Prestazione:
+16.77%
1 anno Prestazione:
+67.29%
Intervallo 1D:
$9.64
$9.89
Intervallo di 1 settimana:
$8.985
$10.08
Portata 52W:
$4.55
$11.85
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Nome
Meiragtx Holdings Plc
Settore
Industria
Telefono
646-860-7985
Indirizzo
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
9.825 | 902.59M | 81.39M | -114.20M | -50.60M | -1.4253 |
VRTX
Vertex Pharmaceuticals Inc
|
428.60 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
718.43 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
811.45 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
304.43 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.57 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-24 | Iniziato | H.C. Wainwright | Buy |
| 2025-10-21 | Iniziato | Raymond James | Strong Buy |
| 2024-07-31 | Ripresa | Chardan Capital Markets | Buy |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-09-15 | Ripresa | BofA Securities | Buy |
| 2019-09-03 | Iniziato | Piper Jaffray | Overweight |
| 2019-02-27 | Reiterato | Chardan Capital Markets | Buy |
| 2018-07-03 | Iniziato | Barclays | Overweight |
| 2018-07-03 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Meiragtx Holdings Plc Borsa (MGTX) Ultime notizie
Will MeiraGTx Holdings PLC (MGTX) report negative Q1 earnings? What you should know - MSN
Will MeiraGTx Holdings PLC (MGTX) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
MeiraGTx Holdings plc ($MGTX) President and CEO 2025 Pay Revealed - Quiver Quantitative
[ARS] MeiraGTx Holdings plc SEC Filing - Stock Titan
MeiraGTx (NASDAQ: MGTX) details pay and board votes for 2026 AGM - Stock Titan
MeiraGTx (MGTX) CMO amends Form 4 for 7,814 tax-withheld shares - Stock Titan
MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? - MSN
MeiraGTx rises on upcoming phase 1 readout for gene therapy - MSN
DAVENPORT & Co LLC Purchases 7,000 Shares of MeiraGTx Holdings Plc (NASDAQ:MGTX) - 富途牛牛
Discipline and Rules-Based Execution in MGTX Response - Stock Traders Daily
Eli Lilly partner MeiraGTx regains rights for genetic eye disease drug from Johnson & Johnson - MSN
MeiraGTx Holdings PLC (MGTX) Q4 earnings and revenues surpass estimates - MSN
Here is Why MeiraGTx Holdings (MGTX) is One of the Best Growth Stocks Under $10 - Yahoo Finance
Perceptive lifts MeiraGTx (NASDAQ: MGTX) ownership to 12.6% with warrants - Stock Titan
MeiraGTx and Hologen Enter Material Definitive Agreements and Collaboration License for Neuro AI – April 2026 - Minichart
MeiraGTx and Hologen finalize collaboration and licensing agreements By Investing.com - Investing.com Nigeria
MeiraGTx and Hologen finalize collaboration and licensing agreements - Investing.com
MeiraGTx acquires J&J's XLRP investigational therapy - Eyes On Eyecare
MeiraGTx (NASDAQ: MGTX) details $200M Hologen CNS gene therapy pact - Stock Titan
MeiraGTx (MGTX) Perceptive funds gain $8 warrants and new shares - Stock Titan
Piper Sandler raises MeiraGTx stock price target to $30 on data - Investing.com Australia
Piper Sandler raises MeiraGTx stock price target to $30 on data By Investing.com - Investing.com Australia
MGTX Maintained by Piper Sandler -- Price Target Raised to $30 - GuruFocus
MeiraGTx (NASDAQ:MGTX) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
What is HC Wainwright's Forecast for MeiraGTx Q1 Earnings? - MarketBeat
Piper Sandler Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $30 - Moomoo
MGTX SEC FilingsMeiragtx Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Richard Giroux Sells 56,000 Shares of MeiraGTx (NASDAQ:MGTX) Stock - MarketBeat
MeiraGTx CFO & COO Richard Giroux sells $572,320 in stock By Investing.com - Investing.com South Africa
MeiraGTx CFO & COO Richard Giroux sells $572,320 in stock - Investing.com
[144] MeiraGTx Holdings plc SEC Filing - Stock Titan
MeiraGTx (MGTX) CFO sells 56,000 shares under 10b5-1 plan - Stock Titan
Genetic Medicines Co. Reveals Transformative 'Only-of-Its-Kind' AAV Therapy Milestone - Streetwise Reports
Latham & Watkins Represents MeiraGTx in US$100 Million Ordinary Shares Offering - Latham & Watkins LLP
MEIRAGTX HOLDINGS PLC : COMPANY ANNOUNCEMENT - marketscreener.com
H.C. Wainwright reiterates MeiraGTx stock rating on gene therapy progress By Investing.com - Investing.com India
H.C. Wainwright reiterates MeiraGTx stock rating on gene therapy progress - Investing.com
MeiraGTx (MGTX) Soars 6.8%: Is Further Upside Left in the Stock? - Yahoo Finance
H.C. Wainwright Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $20 - Moomoo
MeiraGTx Announces Public Equity Offering to Fund Growth - The Globe and Mail
MGTX Maintained by RBC Capital -- Price Target Raised to $24.00 - GuruFocus
Meiragtx Holdings Plc Azioni (MGTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.78%
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):